By Dean Seal
Astrana Health has agreed to buy the businesses and assets of Prospect Health for $745 million and the assumption of certain liabilities.
The healthcare company said Friday that it is acquiring the full Prospect Health System, which includes Prospect's licensed healthcare service plan in California and medical groups in California, Texas, Arizona and Rhode Island.
Astrana is also taking on Prospect's management service organization, the RightRx pharmacy and Alta Newport Hospital, an acute care hospital in California better known as Foothill Regional. Prospect is expected to generate revenue of about $1.2 billion in 2024, along with about $81 million in adjusted Ebitda.
Astrana is funding the acquisition with cash on hand and a $1.1 billion bridge loan from Truist Bank and J.P. Morgan.
The deal is expected to close in the middle of next year, pending regulatory approval.
Prospect is a tenant of Medical Properties Trust, which said Friday that the Astrana acquisition includes the assumption of certain liabilities but didn't go into further detail.
The real estate investment trust said it stands to receive about $200 million in proceeds from the Astrana acquisition, with most of that coming in the first half of 2025 and about $50 million expected by 2027.
Medical Properties Trust reported third-quarter results on Thursday and said Prospect hadn't paid cash rent related to six California properties.
Prospect was attempting to exit multiple east coast markets that were generating losses and impacting overall liquidity, including in Pennsylvania and Rhode Island, the real estate investment trust said.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
November 08, 2024 08:50 ET (13:50 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。